Indivior PLC- 详细介绍、公司背景、业务范围、财务数据以及市场表现

关于 Indivior PLC 公司

Indivior PLC is a global pharmaceutical company engaged in developing medicines to treat substance-use disorders (SUD). The Company provides treatment for addiction, including SUBLOCADE (buprenorphine extended-release) injection for subcutaneous use, a long-acting injectable (LAI) for opioid use disorder and OPVEE (Nalmefene) nasal spray for opioid overdose recovery. Its core products include SUBOXONE Film, SUBOXONE Tablet, SUBUTEX Tablet, OPVEE (nalmefene), and SUBLOCADE. SUBOXONE Film is a buprenorphine and naloxone sublingual film. SUBOXONE Tablet is a buprenorphine and naloxone sublingual tablet. SUBUTEX Tablet is a buprenorphine sublingual tablet. SUBOXONE Film, SUBOXONE Tablet, SUBUTEX Tablet, and SUBLOCADE are treatments for opioid use disorder (OUD). In addition to its commercially available products, its product pipeline includes two drug candidates for the treatment of OUD. The Company sells its products in the United States and in other selected areas of the world.

Indivior PLC简介



公司代码INDV

公司名称Indivior PLC

上市日期Dec 24, 2014

CEOCiaffoni (Joseph J)

员工数量1030

证券类型Ordinary Share

年结日Dec 24

公司地址234 Bath Road

城市SLOUGH

上市交易所NASDAQ OMX - NASDAQ BASIC

国家United Kingdom

邮编SL1 4EE

电话448043791090

网址https://www.indivior.com/en

公司代码INDV

上市日期Dec 24, 2014

CEOCiaffoni (Joseph J)

Indivior PLC公司高管



名称

名称/职务

职务

持股

持股变动

Mr. Christian Heidbreder

Chief Scientific Officer

246.51K

+22.61%

Mr. Vishal Kalia

Chief Impact and Strategy Officer

137.46K

+3.15%

Mr. Joseph J. (Joe) Ciaffoni

Chief Executive Officer, Director

135.98K

--

Mr. Jeffrey W. (Jeff) Burris, Esq., J.D.

Chief Legal Officer

71.52K

+61.33%

Mr. Patrick A. Barry

Chief Commercial Officer

31.38K

--

Mr. Daniel A. (Dan) Ninivaggi, J.D.

Non-Executive Independent Director

20.64K

+5.56%

Ms. Juliet Thompson

Senior Non-Executive Independent Director

13.35K

+43.27%

Dr. Keith Humphreys

Non-Executive Independent Director

9.52K

+27.80%

Ms. Kathryn Barbara Hudson

Company Secretary

--

Ms. Cynthia (Cindy) Cetani

Chief Integrity and Compliance Officer

--

名称

名称/职务

职务

持股

持股变动

Mr. Christian Heidbreder

Chief Scientific Officer

246.51K

+22.61%

Mr. Vishal Kalia

Chief Impact and Strategy Officer

137.46K

+3.15%

Mr. Joseph J. (Joe) Ciaffoni

Chief Executive Officer, Director

135.98K

--

Mr. Jeffrey W. (Jeff) Burris, Esq., J.D.

Chief Legal Officer

71.52K

+61.33%

Mr. Patrick A. Barry

Chief Commercial Officer

31.38K

--

Mr. Daniel A. (Dan) Ninivaggi, J.D.

Non-Executive Independent Director

20.64K

+5.56%

收入明细

单位: USD更新时间: 4月6日周一

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

由于公司未披露，未能获取相关数据

地区USD

名称

营收

占比

United States

267.00M

85.03%

Rest of World

47.00M

14.97%

业务

地区

由于公司未披露，未能获取相关数据

股东统计

更新时间: 15 小时前

持股股东

股东类型

持股股东

占比

BlackRock Institutional Trust Company, N.A.

13.90%

Vanguard Portfolio Management, LLC

6.61%

Oaktree Capital Management, L.P.

5.87%

The Vanguard Group, Inc.

5.39%

Fuller & Thaler Asset Management Inc.

5.27%

其他

62.96%

持股股东

占比

BlackRock Institutional Trust Company, N.A.

13.90%

Vanguard Portfolio Management, LLC

6.61%

Oaktree Capital Management, L.P.

5.87%

The Vanguard Group, Inc.

5.39%

Fuller & Thaler Asset Management Inc.

5.27%

其他

62.96%

股东类型

持股股东

占比

Investment Advisor

37.34%

Investment Advisor/Hedge Fund

26.89%

Hedge Fund

26.65%

Research Firm

7.60%

Individual Investor

4.27%

Pension Fund

3.22%

Bank and Trust

0.48%

Family Office

0.19%

Sovereign Wealth Fund

0.10%

机构持股



更新时间: 4月1日周三

报告期

机构数

持股数

持股占比

持股变动

2026Q1

516

123.98M

102.46%

-10.66M

2025Q4

1

2.06K

0.00%

--

2025Q3

372

118.02M

94.53%

+2.51M

2025Q2

354

123.13M

98.21%

+4.02M

2025Q1

380

119.99M

96.15%

-1.70M

2024Q4

382

116.83M

93.64%

-10.43M

2024Q3

369

117.73M

91.72%

-15.91M

2024Q2

352

119.29M

90.10%

-8.99M

2024Q1

341

129.79M

96.57%

+3.79M

2023Q4

322

124.43M

92.28%

+2.93M

股东持股明细



名称

持股数

占比

持股变动

变动比例

公告日期

BlackRock Institutional Trust Company, N.A.

16.82M

13.8%

+9.03M

+115.92%

Dec 31, 2025

Oaktree Capital Management, L.P.

7.11M

5.83%

-1.64M

-18.71%

Dec 31, 2025

The Vanguard Group, Inc.

5.45M

4.47%

+2.01M

+58.34%

Dec 31, 2025

Fuller & Thaler Asset Management Inc.

6.37M

5.23%

+3.20M

+101.00%

Dec 31, 2025

Madison Avenue Partners LP

6.28M

5.15%

--

Feb 17, 2026

Two Seas Capital LP

5.11M

4.19%

-4.14M

-44.79%

Dec 31, 2025

Millennium Management LLC

4.81M

3.94%

+2.47M

+105.61%

Mar 17, 2026

Morgan Stanley & Co. LLC

3.82M

3.13%

-1.77M

-31.64%

Dec 31, 2025

Sirovich (Matthew I.)

3.42M

2.81%

+249.62K

+7.87%

Sep 30, 2024

持股ETF



更新时间: 12月6日周六

机构名称

占比

Lattice Hartford Multifactor Small Cap ETF

1.11%

ProShares Ultra Nasdaq Biotechnology

0.51%

Federated Hermes MDT Small Cap Core ETF

0.47%

Janus Henderson Small Cap Growth Alpha ETF

0.43%

First Trust Multi-Manager Small Cap Opportunities ETF

0.38%

Invesco Nasdaq Biotechnology ETF

0.36%

Franklin US Small Cap Multifactor Index ETF

0.32%

First Trust Active Factor Small Cap ETF

0.31%

Vanguard US Multifactor ETF

0.27%

Pacer US Small Cap Cash Cows ETF

0.26%

Lattice Hartford Multifactor Small Cap ETF

占比1.11%

ProShares Ultra Nasdaq Biotechnology

占比0.51%

Federated Hermes MDT Small Cap Core ETF

占比0.47%

Janus Henderson Small Cap Growth Alpha ETF

占比0.43%

First Trust Multi-Manager Small Cap Opportunities ETF

占比0.38%

Invesco Nasdaq Biotechnology ETF

占比0.36%

Franklin US Small Cap Multifactor Index ETF

占比0.32%

First Trust Active Factor Small Cap ETF

占比0.31%

Vanguard US Multifactor ETF

占比0.27%

Pacer US Small Cap Cash Cows ETF

占比0.26%

分红派息



近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股



公告日期

除权除息日

类型

比率

暂无数据

公告日期

除权除息日

类型

比率

暂无数据